ROSYY yields 198.02% · JNJ yields 2.13%● Live data
📍 ROSYY pulled ahead of the other in Year 1
Combined, ROSYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROSYY + JNJ for your $10,000?
Public Joint Stock Company Rostelecom provides digital services and solutions in Russia. The company provides Rostelecom Key, an ecosystem of services for households that offers smart intercom, smart gate bar, and smart meter solutions, as well as integrated video surveillance platform; Pay TV; Wink, a digital video services; and smart home services. It also offers antivirus solutions; Wi-Fi 2.0 platform; corporate TV's; virtual BX; toll-free calling 8-800; Game-RT-X routers; IT solutions for municipal solid waste management; video surveillance services; and VDI/VDC and cyber security services. In addition, the company offers NVIDIA, a cloud gaming service; Kapsula, a smart speaker; submarine cables; R&D; maintenance and recreational; engineering design; data and data storage; telecommunication and IT consulting; and engages in leasing of equipment, communication equipment manufacturing, retail, real estate, and venture and pension fund activities. Further, it provides solutions for electronic government, cybersecurity, data center and cloud-based services, biometrics, healthcare, education, house maintenance, and utility services. The company was incorporated in 1993 and is headquartered in Moscow, Russia.
Full ROSYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.